✦ LIBER ✦

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

✍ Scribed by Okamoto, M; Okano, A; Akamatsu, S; Ashihara, E; Inaba, T; Takenaka, H; Katoh, N; Kishimoto, S; Shimazaki, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab for the treatment of corticost

✍ Takanori Teshima; Koji Nagafuji; Hideho Henzan; Koichi Miyamura; Ken Takase; Mic 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 181 KB

Mycophenolate mofetil for the treatment

✍ Marta Krejci; Michael Doubek; Tomas Buchler; Yvona Brychtova; Jiri Vorlicek; Jir 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 82 KB

Daclizumab, an efficient treatment for s

✍ Pierre Bordigoni; Sophie Dimicoli; Laurence Clement; Cédric Baumann; Alexandra S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Chronic graft-versus-host disease: where

✍ Weisdorf, D J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Mesenchymal stromal cell therapy for ste

✍ Richard Herrmann; Marian Sturm; Kathryn Shaw; Duncan Purtill; Julian Cooney; Mat 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 227 KB

Salvage therapy for refractory chronic g

✍ Mookerjee, B; Altomonte, V; Vogelsang, G 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 37 KB